Chronic inflammatory demyelinating polyneuropathy (CIDP) diagnosis involves a neurological exam, nerve conduction studies, electromyography, cerebrospinal fluid analysis, nerve biopsy, and, in ...

Chronic inflammatory demyelinating polyneuropathy diagnosis involves a neurological exam, nerve conduction studies, and electromyography, among other tests and tools.

Vyvgart Hytrulo is a combination of efgartigimod alfa and hyaluronidase. Here’s how it treats chronic inflammatory demyelinating polyneuropathy (CIDP).

Treatment options for chronic inflammatory demyelinating polyneuropathy include intravenous immunoglobulin, corticosteroids, plasmapheresis (plasma exchange), and a newer medication called Vyvgart ...

Treatment for chronic inflammatory demyelinating polyneuropathy can include intravenous immunoglobulin, corticosteroids, plasmapheresis, and Vyvgart Hytrulo.

The Consortium Global IBD Visualization of Epidemiology Studies in the 21st Century (GIVES-21) published data on the global ...

Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

About Chronic Inflammatory Demyelinating Polyneuropathy Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare and serious autoimmune disease of the peripheral nervous system.

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...

Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy Two phase 3 studies are currently underway testing riliprubart in people with CIDP as a ...